What is the most appropriate screening test for Down syndrome in a 40-year-old woman at 12 weeks of gestation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

First-Trimester Combined Screening is Most Appropriate at 12 Weeks

For this 40-year-old woman at 12 weeks gestation requesting Down syndrome screening, the most appropriate test is ultrasound for fetal nuchal translucency (NT) combined with first-trimester serum markers (PAPP-A and free beta-hCG or hCG), which together constitute first-trimester combined screening (Option D forms the foundation, but should be combined with serum markers). 1

Why First-Trimester Combined Screening at 12 Weeks

At 12 weeks gestation, first-trimester combined screening (maternal age + NT + PAPP-A + free beta-hCG) achieves detection rates of 83-86% for Down syndrome at a 5% false-positive rate. 1 This timing is optimal because:

  • NT measurement is most accurate between 11-13 completed weeks gestation, and the patient is currently at the ideal window. 1
  • Free beta-hCG performs better than intact hCG at 11-12 weeks (2-3% higher detection), making it the preferred serum marker at this gestational age. 1, 2
  • For women 35 years and older (this patient is 40), the detection rate exceeds 80% when NT is combined with serum markers. 1

Why Other Options Are Less Appropriate

Triple Test (Option C) and Quadruple Test (Option A)

Both the triple test (AFP, hCG, uE3) and quadruple test (adds inhibin-A) are second-trimester screening tests performed between 15-20 weeks gestation, making them inappropriate for a patient currently at 12 weeks. 1

  • The quadruple screen detects approximately 75% of Down syndrome cases in women younger than 35 years and over 80% in women 35 and older, but requires waiting until 15-20 weeks. 1
  • Delaying screening until the second trimester means missing the opportunity for earlier diagnosis and the option of first-trimester diagnostic testing (CVS) if desired. 1

Nasal Bone Detection Alone (Option B)

While absent nasal bone between 11-13 weeks is a useful Down syndrome marker, it requires additional specialized training and should not be used as a standalone screening test. 1

  • Nasal bone evaluation requires demonstration of proficiency beyond standard NT measurement and needs further validation for routine screening in the United States. 1
  • It serves as an adjunct marker, not a primary screening modality. 1

NT Alone (Option D as stated)

While NT measurement is essential, using it without serum markers significantly reduces detection rates. 1

  • NT measurement alone (with maternal age) has lower sensitivity than combined screening. 1
  • The combination of NT with PAPP-A and free beta-hCG increases detection rates by approximately 20-25% compared to NT alone. 1

Optimal Screening Strategy for This Patient

The complete first-trimester combined screening protocol should include:

  1. Ultrasound measurement of nuchal translucency between 11-13 completed weeks (patient is at 12 weeks—ideal timing). 1
  2. Maternal serum PAPP-A measurement. 1
  3. Maternal serum free beta-hCG (preferred at 12 weeks over intact hCG). 1, 2
  4. Integration with maternal age (40 years—high-risk category). 1

Critical Considerations for Advanced Maternal Age

At age 40, this patient has significantly elevated baseline risk for Down syndrome, making accurate screening particularly important. 1

  • Women 35 and older achieve detection rates exceeding 80% with combined first-trimester screening. 1
  • Given her age, she should also be counseled about the option of diagnostic testing (CVS or amniocentesis) rather than screening alone. 1
  • If first-trimester combined screening shows high risk, CVS can be offered immediately rather than waiting for second-trimester amniocentesis. 1

Important Pitfalls to Avoid

Do not delay screening to the second trimester when the patient presents at an optimal time for first-trimester testing. 1 Early screening provides:

  • Earlier diagnosis if abnormalities are detected. 1
  • More pregnancy management options. 1
  • Reduced anxiety from earlier reassurance if results are normal. 1

Ensure NT measurements are performed by properly trained and credentialed sonographers, as technique significantly affects accuracy. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Beta-hCG Levels and Pregnancy Progression

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.